Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
04/2014
04/23/2014CN102716495B Multifunctional poly(malic acid) carried drug for targeting treatment of tumors
04/23/2014CN101636145B Long term 24 hour intestinal administration of levodopa/carbidopa
04/22/2014US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
04/22/2014US8703781 Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors
04/22/2014US8703764 Combination therapy for dementia, depression and apathy
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703211 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
04/22/2014US8703199 Pharmaceutical compositions of adsorbates of amorphous drug
04/22/2014US8703152 Methods of treating inflammatory intestinal disease and managing symptoms thereof
04/22/2014US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody
04/22/2014CA2751187C Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
04/22/2014CA2611451C Solid preparation
04/22/2014CA2561530C Therapeutic or prophylactic agent for arthritis
04/22/2014CA2550294C Canine probiotic lactobacilli
04/22/2014CA2548135C Synthetic hla binding peptide analogues and uses thereof
04/17/2014WO2014059151A1 Method and device for reducing dermal filler adverse events
04/17/2014WO2014059022A1 Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
04/17/2014WO2014058785A1 Combination therapy
04/17/2014WO2014058047A1 Method for producing pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist
04/17/2014WO2014058046A1 Pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist
04/17/2014WO2014056894A1 Mek inhibitors in the treatment of virus diseases
04/17/2014WO2014056840A1 Beta-2-adrenoceptor agonist for the treatment of cough
04/17/2014WO2014056779A1 Drug for the prophylaxis and treatment of a neurodegenerative disease
04/17/2014WO2014030049A3 Compositions comprising a single variable domain and camostat mesylate (cm)
04/17/2014US20140107391 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
04/17/2014US20140107225 Therapeutic application of cembranoids against hiv virus replication, hiv-associated neurocognitive disorders and hiv virus-induced inflammation.
04/17/2014US20140107218 Methods for maintaining eye health and ameliorating opthalmic maladies in animals
04/17/2014US20140107212 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
04/17/2014US20140107197 Pharmaceutical composition
04/17/2014US20140107196 Anti-cancer lead molecule
04/17/2014US20140107177 Methods and Compositions for Transdermal Delivery of Nucleotides
04/17/2014US20140107173 Compositions and Methods for Treatment of Glaucoma
04/17/2014US20140107172 Benzimidazole-imidazole derivatives
04/17/2014US20140107170 Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties
04/17/2014US20140107151 Tyrosine kinase inhibitors
04/17/2014US20140107146 Abuse-resistant controlled-release opioid dosage form
04/17/2014US20140107135 Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2
04/17/2014US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics
04/17/2014US20140107120 Dual-acting benzoimidazole antihypertensive agents
04/17/2014US20140107119 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
04/17/2014US20140107116 Benzothiazole derivatives for the treatment of diabetes
04/17/2014US20140107113 Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist
04/17/2014US20140107101 Macrocyclic Indole Derivatives Useful as Hepatitis C Virus Inhibitors
04/17/2014US20140107097 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107096 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107095 Estrogen receptor modulators and uses thereof
04/17/2014US20140107094 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107087 Methods, Compounds and Pharmaceutical Compositions for Treating Anxiety and Mood Disorders
04/17/2014US20140107085 Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof
04/17/2014US20140107084 Ultra low dose doxepin and methods of using the same to treat sleep disorders
04/17/2014US20140107083 Treatment of congestion using steroids and adrenergics
04/17/2014US20140107079 Beta-hydroxy-gamma-aminophosphonates for Treating Immune Disorders
04/17/2014US20140107063 Osteoarthritis diet formulations
04/17/2014US20140107057 Pesticidal mixtures including isoxazoline derivatives
04/17/2014US20140107050 Increasing bioavailability of n-coumaroyldopamine through co-administration with a catechol-o-mehtyltransferase (comt) inhibitor
04/17/2014US20140107040 Substituted n-aryl pyridinones
04/17/2014US20140107038 Method for administering omega-conopeptide
04/17/2014US20140107025 Ocular drug delivery system
04/17/2014US20140107024 Treatment of Type 2 Diabetes With FTY720
04/17/2014US20140107014 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
04/17/2014US20140106012 Compositions and methods useful for treating pediculosis
04/17/2014US20140106005 Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms
04/17/2014US20140106004 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
04/17/2014US20140106001 Marine extract compositions and methods of use
04/17/2014US20140105997 Galectin-3 plasmapheresis therapy
04/17/2014US20140105987 Abuse-deterrent pharmaceutical compositions of opioids and other drugs
04/17/2014US20140105985 Topical use of levofloxacin for reducing lung inflammation
04/17/2014US20140105969 Compositions and Methods for Treating Cancer
04/17/2014US20140105956 Biodegradable polymer based microimplant for ocular drug delivery
04/17/2014US20140105932 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
04/17/2014US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis
04/17/2014US20140105914 Humanised anti ctla-4 antibodies
04/17/2014US20140105912 Vista modulators for diagnosis and treatment of cancer
04/17/2014US20140105908 Methods for treating prostate cancer
04/17/2014US20140105900 Methods and compositions relating to anti-il-21 receptor antibodies
04/17/2014US20140105896 Fibronectin based scaffold domain proteins that bind to myostatin
04/17/2014US20140105895 Treatment of solid tumors with rapamycin derivatives
04/17/2014US20140105886 Association of biomarkers with patient outcome
04/17/2014US20140105876 Ceramic biocomposite for bone regeneration
04/17/2014US20140105864 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
04/17/2014US20140105860 Engineered antibody-tnfsf member ligand fusion molecules
04/17/2014US20140105859 Modulators of pharmacokinetic properties of therapeutics
04/17/2014US20140105854 Vaccine for treatment and prevention of herpes simplex virus infection
04/17/2014US20140105851 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
04/17/2014US20140105850 Treatment of multiple sclerosis with laquinimod
04/17/2014US20140105828 Nanoparticles caring nucleic acid cassettes for expressing rna
04/17/2014US20140105818 Novel Vesicles and Nanostructures from Recombinant Proteins
04/17/2014DE102012218733A1 Kosmetische oder dermatologische Zubereitung zur Prophylaxe und/oder Behandlung atopischer Dermatitis Cosmetic or dermatological composition for the prophylaxis and / or treatment of atopic dermatitis
04/16/2014EP2719288A1 Composition for the treatment or prevention of dyslipidaemias
04/16/2014EP2717880A1 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
04/16/2014EP2717868A1 Combination comprising umeclidinium and a corticosteroid
04/16/2014EP2717867A1 Dry powder inhaler compositions comprising umeclidinium
04/16/2014CN103732226A mTOR/JAK inhibitor combination therapy
04/16/2014CN103721263A Oil injection containing antibacterial agents/polyethylene glycol drug-loading particles
04/16/2014CN103721262A Preparation type of manganese-zinc-selenium supplement and beverage preparation method thereof
04/16/2014CN103721261A Pharmaceutical composition containing SGLT2 (sodium-glucose type 2 transporter) inhibitors and group B vitamins as well as application thereof
04/16/2014CN103721260A Oily injection containing antiparasitic agent/polyethylene glycol drug-loading microparticles
04/16/2014CN103721259A Angiotensin II receptor blocker/thiazide diuretics/5-methyltetrahydrofolate pharmaceutical composition
04/16/2014CN103721258A Compositions and methods for treating asthma and other pulmonary diseases
04/16/2014CN103721257A Serial drug capable of catalyzing decomposition of hydrogen dioxide by phytochromes
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1151